Autism spectrum disorder

8 trials 2 recruiting MedDRA PT
8 Registered trials
2 Recruiting
7 Unique sponsors
8 Unique IMPs
4 Commercial trials
Drug classes (ATC)
— ATC code not specified 6
N Neurology/Psychiatry (ATC N) 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 8 substances
Phase III: 2 Phase II/III: 1 Phase II: 4 Phase I (Other): 1

Filter these 8 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 8 trials

Phase III

2 trials
  • Bristol-Myers Squibb Services Unlimited Company Commercial
    TROSPIUM CHLORIDE, XANOMELINE TARTRATE; XANOMELINE TARTRATE
    2025-524062-16-00 1 country n=40
    Pending
  • Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon Academic
    ARBACLOFEN
    2023-508407-20-00 2 countries 2025 n=105
    Recruiting

Phase II/III

1 trial
  • Centre Hospitalier Universitaire De Nantes Academic
    IMP not specified
    2024-516306-28-00 1 country 2025 n=30
    Recruiting

Phase II

4 trials
  • Acadia Pharmaceuticals Inc. Commercial
    PIMAVANSERIN TARTRATE
    2024-512202-25-00 5 countries 2023 n=191
    Ended
  • Bioprojet Pharma Commercial
    PITOLISANT
    2023-503678-18-00 4 countries 2023 n=58 Orphan
    Ended
  • Assistance Publique Hopitaux De Paris Academic
    ALLOGENEIC FAECAL MICROBIOTA, POOLED
    2025-520539-17-00 1 country n=5
    Pending
  • Assistance Publique Hopitaux De Paris Academic
    ALDESLEUKIN
    2025-522841-23-00 1 country n=22
    Pending

Phase I (Other)

1 trial
  • Cell2cure ApS Commercial
    ALLOGENIC ADIPOSE-TISSUE-DERIVED MESENCHYMAL STEM CELLS
    2025-523699-21-00 1 country n=40
    Not authorised
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Assistance Publique Hopitaux De Paris Academic 2 Phase II 0
Cell2cure ApS Commercial 1 Phase I (Other) 0
Acadia Pharmaceuticals Inc. Commercial 1 Phase II 0
Bioprojet Pharma Commercial 1 Phase II 0
Bristol-Myers Squibb Services Unlimited Company Commercial 1 Phase III 0
Centre Hospitalier Universitaire De Nantes Academic 1 Phase II/III 1
Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon Academic 1 Phase III 1
New trials by year
2023
2
2025
2
← All indication landscapes